Alfasigma España, S.L. company information, Employees & Contact Information

Filgotinib Shows Positive Topline Results Across Full Spectrum of Axial Spondyloarthritis in OLINGUITO Phase 3 Study Yahoo Finance

Alfasigma touts results from phase 3 trial of former Galapagos JAK inhibitor Jyseleca Fierce Pharma

Alfasigma to seek expanded filgotinib label after trial success The Pharma Letter

Alfasigma Invests MX$100 Million to Expand OTC Business in Mexico Mexico Business News

Intercept Announces Voluntary Withdrawal of OCALIVA® for Primary Biliary Cholangitis (PBC) from the US Market; US Clinical Trials Involving Obeticholic Acid Placed on Clinical Hold Yahoo Finance

Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc. Business Wire

Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial The Lancet

Alfasigma sets stage for Jyseleca in axSpA after Phase III win Pharmaceutical Technology

ALFASIGMA ANNOUNCES THE AGREEMENT FOR THE ACQUISITION OF 100% OF SOFAR, ITALIAN PHARMACEUTICAL COMPANY PR Newswire UK

Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 GlobeNewswire

Alfasigma acquires Lumeblue™ (Methylene Blue MMX) rights for EU distribution, consolidating its Gastro-Intestinal portfolio PR Newswire

Alfasigma to acquire Jyseleca from Galapagos European Pharmaceutical Review

Alfasigma Withdraws Zelnorm from Market Managed Healthcare Executive

Intercept, after biotech rollercoaster ride, agrees to buyout by Alfasigma BioPharma Dive

Alfasigma S.p.A. successfully completes tender offer for all outstanding shares of common stock of Intercept Pharmaceuticals, Inc. Business Wire

Alfasigma to buy Intercept Pharmaceuticals for $794m Pharmaceutical Technology

After 2 FDA rejections and restructuring drive, Intercept sells itself to Italy's Alfasigma Fierce Pharma

Alfasigma The Pharma Letter

Alfasigma opens new doors in the US with Intercept acquisition Pharmaceutical Technology

Liver disease drug developer Intercept to be acquired by Alfasigma FirstWord Pharma

Alfasigma SpA set to take over Galapagos programme European Biotechnology Magazine

Alfasigma to buy Galapagos’ JAK drug for up to €170m pharmaphorum

Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery ScienceDirect.com

Alfasigma scoops up Intercept Pharmaceuticals in $794M buyout Medical Marketing and Media

Alfasigma USA, Inc. Engages Indegene, Inc. to Expand the GlobeNewswire

The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice Frontiers

Alfasigma reaches deal to buy Intercept for $800m pharmaphorum

Alfasigma launches its first full digital hackathon - Alfathon PR Newswire UK

Alfasigma SpA signs €170m deal with Galapagos NV European Biotechnology Magazine

Alfasigma accelerates investment in the food supplements segment, driven by significant growth in the Romanian and regional markets business-review.eu

After NASH Hopes Are Dashed, Intercept Pharma Agrees to $794M Buyout MedCity News

Alfasigma to acquire Galapagos' Jyseleca business The Pharma Letter

Alfasigma: Jacopo Murzi is the new General Manager of the Italy Business Unit PR Newswire UK

Intercept failed NASH candidate precipitated Alfasigma acquisition Seeking Alpha

ALFASIGMA ACQUIRES THE ENTIRE SHARE CAPITAL OF SOFAR, AN ITALIAN PHARMACEUTICAL COMPANY PR Newswire UK

Alfasigma acquires the European license for bentracimab from PhaseBio PR Newswire UK

Alfasigma secures 150 mln eur EIB loan for rare diseases and specialty care Eunews

Pharmaceutical company Alfasigma introduces new food supplement in Romania, promises further expansion Romania Insider

Salix And Alfasigma Will Initiate Late-Stage Program To Study Rifaximin In Patients With Postoperative Crohn's Disease PR Newswire

Bausch Health, Alfasigma resolve Xifaxan litigation with Sun Pharma Drug Store News

Italy’s private debt & corporate finance weekly round-up. News from SEA, F2i, Alfasigma, Banco BPM, GIVA, Crédit Agricole Italia, BNL BNP Paribas, Banco BPM, Banca Monte dei Paschi di Siena, Banca Popolare di Sondrio, and more – BeBeez International BeBeez International

Bosch updates fire alarm, intrusion detection and video security systems at Alfasigma’s offices in Italy SourceSecurity.com

Alfasigma, the new Italian pharmaceutical hub is born firstonline.info

ALFASIGMA TOURNAMENT Virtus Bologna

Virtus Bologna wins Alfasigma tournament Virtus Bologna